University of Minnesota Medical School Investigators to Lead Study Investigating Efficacy of Metformin Targeting COVID-19

University of Minnesota Medical School Investigators to Lead Study Investigating Efficacy of Metformin Targeting COVID-19

The University of Minnesota Medical School received funding from the Parsemus Foundation to start a study focusing on the widely-used diabetes medication known as metformin. The key question: can this economical and available drug be used to help fight COVID-19? A randomized, controlled study planned will help two co-principal investigators pursue what could be a materially breakthrough in the search for treatments targeting COVID-19. Although the recent grant support from the Parsemus Foundation is a healthy start, the University of Minnesota investigators need additional capital to complete the entire clinical trial. 

An Important Goal: A Generic Low Cost Approach Targeting COVID-19

The CDC forecasts predict 1,300 to 5,500 new COVID-19 hospitalizations per day by Oct. 12 in the U.S. alone. This means that a treatment that reduces hospitalization by about 50-60%, as evidenced by observational data, could potentially prevent thousands of hospitalizations each day in the U.S.. With generics available for less than $4 per month from manufacturers around the globe, metformin also has the advantage that it can be used immediately and inexpensively worldwide. Metformin is al...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee